Merck & Co. said Tuesday that it would acquire eye treatment maker Inspire Pharmaceuticals Inc. for about $430 million to expand its ophthalmology business. Get the full story »
Inspire
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
